Studies have shown that VEGFA can affect the infiltration of CD163+ TAM in bladder cancer (22), and the changes in VEGF receptor expression are linked to the disease staging and recurrence of bladder cancer (23). The gene discussed is VEGFA; the disease is urinary bladder carcinoma.